Patent Assignment
Reel/Frame 021733/0840
Assignment of Assignor's Interest
Recorded: 2008-10-24
Pages: 21
Assignor
CZARNIK, ANTHONY W
Executed: 2008-10-22
Assignee
PROTIA, LLC
15025 BROILI DR, RENO, NEVADA, 89511
Covered Properties
(249)
Deuterium-Enriched Alendronate
Application:
12/195,504 →
Publication:
US 2009/0118238
Deuterium-Enriched Amlodipine
Application:
12/195,517 →
Publication:
US 2009/0062352
Deuterium-Enriched Asenapine
Application:
12/195,529 →
Publication:
US 2009/0209608
Deuterium-Enriched Azithromycin
Application:
12/195,540 →
Publication:
US 2009/0062220
Deuterium-Enriched Celecoxib
Application:
12/195,553 →
Publication:
US 2009/0062364
Deuterium-Enriched Cetirizine
Application:
12/195,569 →
Publication:
US 2009/0062305
Deuterium-Enriched Eletriptan
Application:
12/195,581 →
Publication:
US 2009/0062367
Deuterium-Enriched Linezolid
Application:
12/195,589 →
Publication:
US 2009/0062283
Deuterium-Enriched Sertraline
Application:
12/195,593 →
Publication:
US 2009/0062399
Deuterium-Enriched Sildenafil
Application:
12/195,599 →
Publication:
US 2009/0062298
Deuterium-Enriched Atorvastatin
Application:
11/745,704 →
Publication:
US 2008/0280970
Deuterium-Enriched Atorvastatin
Deuterium-Enriched Doxazosin
Application:
12/195,807 →
Publication:
US 2009/0062299
Deuterium-Enriched Ziprasidone
Application:
12/195,826 →
Publication:
US 2009/0062303
Deuterium-Enriched Voriconazole
Application:
12/195,857 →
Publication:
US 2009/0062310
Deuterium-Enriched Sunitinib
Application:
12/195,881 →
Publication:
US 2009/0062368
Deuterium-Enriched Tiotropium
Application:
12/195,907 →
Publication:
US 2009/0062325
Deuterium-Enriched Irinotecan
Application:
12/195,936 →
Publication:
US 2009/0062323
Deuterium-Enriched Fluconazole
Application:
12/195,956 →
Publication:
US 2009/0062357
Deuterium-Enriched Gabapentin
Application:
12/195,978 →
Publication:
US 2009/0062392
Deuterium-Enriched Indiplon
Application:
12/196,003 →
Publication:
US 2009/0062312
Deuterium-Enriched Tolterodine
Application:
12/196,022 →
Publication:
US 2009/0062398
Deuterium-Enriched Budesonide
Application:
12/196,041 →
Publication:
US 2009/0082319
Deuterium-Enriched Ciprofloxacin
Application:
12/196,053 →
Publication:
US 2009/0069339
Deuterium-Enriched Lestaurtinib
Application:
11/754,390 →
Publication:
US 2008/0299215
Deuterium-Enriched Oxybutynin
Deuterium-Enriched Sorafenib
Application:
12/196,151 →
Publication:
US 2009/0069388
Deuterium-Enriched Sugammadex
Application:
12/196,166 →
Publication:
US 2009/0069412
Deuterium-Enriched Aripiprazole
Application:
11/757,319 →
Publication:
US 2008/0299216
Deuterium-Enriched Atrasentan
Application:
12/196,176 →
Publication:
US 2009/0069402
Deuterium-Enriched Famotidine
Application:
12/196,181 →
Publication:
US 2009/0069395
Deuterium-Enriched Moxifloxacin
Application:
11/758,690 →
Publication:
US 2008/0306105
Deuterium-Enriched Escitalopram
Application:
11/762,818 →
Publication:
US 2008/0312318
Deuterium-Enriched Fenofibrate
Application:
11/760,811 →
Publication:
US 2008/0306151
Deuterium-Enriched Montelukast
Application:
11/766,140 →
Publication:
US 2008/0319007
Deuterium-Enriched Olanzapine
Application:
11/765,432 →
Publication:
US 2009/0005366
Deuterium-Enriched Clopidogrel
Application:
11/765,434 →
Publication:
US 2008/0319004
Deuterium-Enriched Eszopiclone
Application:
11/765,435 →
Publication:
US 2008/0318964
Deuterium-Enriched Ezetimibe
Application:
11/765,437 →
Publication:
US 2008/0318920
Deuterium-Enriched Fluticasone Propionate
Application:
11/765,657 →
Publication:
US 2008/0318915
Deuterium-Enriched Oseltamivir
Deuterium-Enriched Salmeterol
Application:
11/766,080 →
Publication:
US 2008/0319086
Deuterium-Enriched Tenofovir
Application:
11/765,677 →
Publication:
US 2008/0318904
Deuterium-Enriched Tamsulosin
Application:
11/762,810 →
Publication:
US 2008/0312328
Deuterium-Enriched Pantoprazole
Application:
12/196,191 →
Publication:
US 2009/0076089
Deuterium-Enriched Alfuzosin
Application:
12/196,198 →
Publication:
US 2009/0076043
Deuterium-Enriched Alvimopan
Application:
12/196,205 →
Publication:
US 2009/0076082
Deuterium-Enriched Ambrisentan
Application:
12/196,211 →
Publication:
US 2009/0069353
Deuterium-Enriched Aroxifene
Application:
12/196,212 →
Publication:
US 2009/0069380
Deuterium-Enriched Bifeprunox
Application:
11/757,322 →
Publication:
US 2008/0299217
Deuterium-Enriched Valsartan
Application:
11/757,325 →
Publication:
US 2008/0299218
Deuterium-Enriched Bortezomib
Application:
12/196,216 →
Publication:
US 2009/0076031
Deuterium-Enriched Bosentan
Application:
12/196,225 →
Publication:
US 2009/0069351
Deuterium-Enriched Bupropion
Application:
12/196,231 →
Publication:
US 2009/0076161
Deuterium-Enriched Capecitabine
Deuterium-Enriched Ciclesonide
Application:
12/196,240 →
Publication:
US 2009/0075959
Deuterium-Enriched Deferasirox
Application:
12/196,242 →
Publication:
US 2009/0082412
Deuterium-Enriched Diclofenac
Application:
12/196,248 →
Publication:
US 2009/0082450
Deuterium-Enriched Disufenton
Application:
12/196,251 →
Publication:
US 2009/0082454
Deuterium-Enriched Dronedarone
Application:
12/196,253 →
Publication:
US 2009/0076137
Deuterium-Enriched Atazanavir
Application:
12/196,255 →
Publication:
US 2009/0076097
Deuterium-Enriched Atomoxetine
Application:
12/196,259 →
Publication:
US 2009/0069440
Deuterium-Enriched Clazosentan
Application:
12/196,326 →
Publication:
US 2009/0069352
Deuterium-Enriched Conivaptan
Application:
12/196,330 →
Publication:
US 2009/0069295
Deuterium-Enriched Dasatinib
Application:
12/196,336 →
Publication:
US 2009/0076025
Deuterium-Enriched Donepezil
Deuterium-Enriched Efavirenz
Application:
12/196,347 →
Publication:
US 2009/0075991
Deuterium-Enriched Eltrombopag
Application:
12/196,359 →
Publication:
US 2009/0076112
Deuterium-Enriched Enzastaurin
Application:
12/196,365 →
Publication:
US 2009/0069377
Deuterium-Enriched Erlotinib
Application:
12/196,369 →
Publication:
US 2009/0076042
Deuterium-Enriched Fulvestrant
Application:
12/196,380 →
Publication:
US 2009/0082323
Deuterium-Enriched Gemcitabine
Application:
12/196,388 →
Publication:
US 2009/0069354
Deuterium-Enriched Glimepiride
Application:
12/196,395 →
Publication:
US 2009/0076125
Deuterium-Enriched Ibandronate
Application:
12/196,581 →
Publication:
US 2009/0075944
Deuterium-Enriched Iclaprim
Application:
12/196,599 →
Publication:
US 2009/0069357
Deuterium-Enriched Ixabepilone
Application:
12/196,627 →
Publication:
US 2009/0076099
Deuterium-Enriched Lapatinib
Application:
12/196,653 →
Publication:
US 2009/0215802
Deuterium-Enriched Lenalidomide
Deuterium-Enriched Letrozole
Application:
12/196,688 →
Publication:
US 2009/0082413
Deuterium-Enriched Lisdexamfetamine
Application:
12/196,702 →
Publication:
US 2009/0082465
Deuterium-Enriched Lurasidone
Application:
12/196,722 →
Publication:
US 2009/0076027
Deuterium-Enriched Memantine
Application:
12/196,740 →
Publication:
US 2009/0076165
Deuterium-Enriched Meropenem
Application:
12/196,773 →
Publication:
US 2009/0082327
Deuterium-Enriched Methylnaltrexone
Application:
12/196,793 →
Publication:
US 2009/0076051
Deuterium-Enriched Miglustat
Application:
12/196,823 →
Publication:
US 2009/0069375
Deuterium-Enriched Modafinil
Application:
12/196,848 →
Publication:
US 2009/0082461
Deuterium-Enriched Muraglitazar
Application:
12/196,867 →
Publication:
US 2009/0076102
Deuterium-Enriched Nalmefene
Application:
12/196,879 →
Publication:
US 2009/0076052
Deuterium-Enriched Naltrexone
Application:
12/196,895 →
Publication:
US 2009/0082382
Deuterium-Enriched Octreotide
Application:
12/196,914 →
Publication:
US 2009/0082259
Deuterium-Enriched Olopatadine
Application:
12/196,938 →
Publication:
US 2009/0069413
Deuterium-Enriched Paclitaxel
Application:
12/196,958 →
Publication:
US 2009/0069410
Deuterium-Enriched Pemetrexed
Application:
12/196,975 →
Publication:
US 2009/0069349
Deuterium-Enriched Prasugrel
Deuterium-Enriched Pravastatin
Application:
12/197,015 →
Publication:
US 2009/0076148
Deuterium-Enriched Quetiapine
Application:
12/197,025 →
Publication:
US 2009/0082334
Deuterium-Enriched Raloxifene
Application:
12/197,038 →
Publication:
US 2009/0069381
Deuterium-Enriched Risedronate
Application:
12/197,050 →
Publication:
US 2009/0075940
Deuterium-Enriched Rivastigmine
Application:
12/233,638 →
Publication:
US 2009/0082436
Deuterium-Enriched Anidulafungin
Application:
12/198,027 →
Publication:
US 2009/0062185
Deuterium-Enriched Axitinib
Application:
12/198,034 →
Publication:
US 2009/0062347
Deuterium-Enriched Hydromorphone
Application:
12/207,849 →
Publication:
US 2009/0076135
Deuterium-Enriched Rosuvastatin
Application:
12/233,271 →
Publication:
US 2009/0082380
Deuterium-Enriched Ruboxistaurin
Application:
12/203,331 →
Publication:
US 2012/0136037
Deuterium-Enriched Tacrolimus
Application:
12/202,275 →
Publication:
US 2009/0069366
Deuterium-Enriched Prazosin
Application:
12/198,042 →
Publication:
US 2009/0062300
Deuterium-Enriched Pregabalin
Application:
12/198,045 →
Publication:
US 2009/0062393
Deuterium-Enriched Tegaserod
Application:
12/233,641 →
Publication:
US 2009/0082419
Deuterium-Enriched Tesaglitazar
Application:
12/233,285 →
Publication:
US 2009/0082441
Deuterium-Enriched Tiagabine
Application:
12/233,301 →
Publication:
US 2009/0082401
Deuterium-Enriched Tipranavir
Application:
12/198,050 →
Publication:
US 2009/0062346
Deuterium-Enriched Varenicline
Application:
12/198,054 →
Publication:
US 2009/0062257
Deuterium-Enriched Vernakalant
Application:
12/202,276 →
Publication:
US 2009/0069404
Deuterium-Enriched Vildagliptin
Application:
12/233,322 →
Publication:
US 2009/0082420
Deuterium-Enriched Vinflunine
Application:
12/206,212 →
Publication:
US 2009/0076055
Deuterium-Enriched Viramidine
Application:
12/233,645 →
Publication:
US 2009/0082414
Deuterium-Enriched Zoledronic Acid
Application:
12/233,330 →
Publication:
US 2009/0082312
Deuterium-Enriched Maraviroc
Application:
12/198,058 →
Publication:
US 2009/0062331
Deuterium-Enriched Fesoterodine
Application:
12/198,064 →
Publication:
US 2009/0062385
Deuterium-Enriched Lasofoxifene
Application:
12/198,069 →
Publication:
US 2009/0062374
Deuterium-Enriched Latanoprost
Application:
12/198,074 →
Publication:
US 2009/0062561
Deuterium-Enriched Pf-184298
Application:
12/198,082 →
Publication:
US 2009/0062373
Deuterium-Enriched Dalbavancin
Application:
12/198,088 →
Publication:
US 2009/0062182
Deuterium-Enriched Pelitrexol
Application:
12/198,090 →
Publication:
US 2009/0062316
Deuterium-Enriched Milnacipran
Application:
12/203,348 →
Publication:
US 2009/0069431
Deuterium-Enriched Sdx-101
Deuterium-Enriched Apixaban
Application:
12/206,223 →
Publication:
US 2009/0076069
Deuterium-Enriched Armodafinil
Application:
12/233,354 →
Publication:
US 2009/0082462
Deuterium-Enriched Aztreonam
Application:
12/203,363 →
Publication:
US 2009/0069286
Deuterium-Enriched Entecavir
Application:
12/206,281 →
Publication:
US 2009/0076038
Deuterium-Enriched Frovatriptan
Application:
12/203,369 →
Publication:
US 2009/0069399
Deuterium-Enriched Nebivolol
Application:
12/203,386 →
Publication:
US 2009/0069415
Deuterium-Enriched Olmesartan
Application:
12/203,472 →
Publication:
US 2009/0069397
Deuterium-Enriched Rufinamide
Application:
12/203,487 →
Publication:
US 2009/0069390
Deuterium-Enriched Saxagliptin
Application:
12/205,590 →
Publication:
US 2009/0076118
Deuterium-Enriched Amoxicilin
Application:
12/205,607 →
Publication:
US 2009/0075965
Deuterium-Enriched Bicalutamide
Application:
12/205,627 →
Publication:
US 2009/0076158
Deuterium-Enriched Fosamprenavir
Application:
12/205,637 →
Publication:
US 2009/0075942
Deuterium-Enriched Lamotrigine
Application:
12/205,653 →
Publication:
US 2009/0076010
Deuterium-Enriched Nelarabine
Deuterium-Enriched Odansetron
Deuterium-Enriched Odiparcil
Application:
12/205,691 →
Publication:
US 2009/0075914
Deuterium-Enriched Radafaxine
Application:
12/206,295 →
Publication:
US 2009/0075994
Deuterium-Enriched Retapamulin
Application:
12/205,701 →
Publication:
US 2009/0076071
Deuterium-Enriched Clarithromycin
Application:
12/202,278 →
Publication:
US 2009/0069255
Deuterium-Enriched Telavancin
Application:
12/202,277 →
Publication:
US 2009/0069219
Deuterium-Enriched Aliskiren
Application:
12/196,576 →
Publication:
US 2009/0082458
Deuterium-Enriched Alogliptin
Application:
12/196,597 →
Publication:
US 2009/0082376
Deuterium-Enriched Amibegron
Application:
12/196,623 →
Publication:
US 2009/0076145
Deuterium-Enriched Aprepitant
Application:
12/196,654 →
Publication:
US 2009/0076007
Deuterium-Enriched Arformoterol
Application:
12/196,677 →
Publication:
US 2009/0306215
Deuterium-Enriched Bazedoxifene
Application:
12/196,692 →
Publication:
US 2009/0076144
Deuterium-Enriched Bendamustine
Application:
12/196,711 →
Publication:
US 2009/0082416
Deuterium-Enriched Bms-690514
Application:
12/196,734 →
Publication:
US 2009/0076034
Deuterium-Enriched Bromfenac
Application:
12/196,751 →
Publication:
US 2009/0076150
Deuterium-Enriched Ceftriaxone
Application:
12/196,762 →
Publication:
US 2009/0075967
Deuterium-Enriched Dapoxetine
Application:
12/196,788 →
Publication:
US 2009/0076163
Deuterium-Enriched Darunavir
Application:
12/196,828 →
Publication:
US 2009/0076138
Deuterium-Enriched Decitabine
Application:
12/196,853 →
Publication:
US 2009/0075920
Deuterium-Enriched Desvenlafaxine
Application:
12/196,866 →
Publication:
US 2009/0076162
Deuterium-Enriched Caspofungin
Application:
12/196,886 →
Publication:
US 2009/0075870
Deuterium-Enriched Dianicline
Application:
12/196,898 →
Publication:
US 2009/0076059
Deuterium-Enriched Doripenem
Application:
12/196,920 →
Publication:
US 2009/0075969
Deuterium-Enriched Dutasteride
Application:
12/196,942 →
Publication:
US 2009/0076057
Deuterium-Enriched Ed-71
Application:
12/196,952 →
Publication:
US 2009/0075953
Deuterium-Enriched Enalapril
Application:
12/210,280 →
Publication:
US 2009/0076126
Deuterium-Enriched Fingolimod
Application:
12/196,977 →
Publication:
US 2009/0082471
Deuterium-Enriched Fluvastatin
Application:
12/196,991 →
Publication:
US 2009/0082418
Deuterium-Enriched Fondaparinux
Application:
12/197,007 →
Publication:
US 2009/0075910
Deuterium-Enriched Fospropofol
Application:
12/197,022 →
Publication:
US 2009/0075947
Deuterium-Enriched GSK625433
Application:
12/197,042 →
Publication:
US 2009/0076100
Deuterium-Enriched Guanfacine
Application:
12/197,055 →
Publication:
US 2009/0082459
Deuterium-Enriched Itraconazole
Application:
12/207,861 →
Publication:
US 2009/0076028
Deuterium-Enriched Levetiracetam
Application:
12/233,651 →
Publication:
US 2009/0082422
Deuterium-Enriched Methylphenidate
Application:
12/207,879 →
Publication:
US 2009/0076079
Deuterium-Enriched Mycophenolate Mofetil
Application:
12/207,894 →
Publication:
US 2009/0076000
Deuterium-Enriched Nicorandil
Application:
12/208,621 →
Publication:
US 2009/0076095
Deuterium-Enriched Nicraven
Application:
12/208,639 →
Publication:
US 2009/0076085
Deuterium-Enriched Paliperidone
Application:
12/208,653 →
Publication:
US 2009/0076035
Deuterium-Enriched Palosetron
Application:
12/208,859 →
Publication:
US 2009/0227623
Deuterium-Enriched Ranolazine
Application:
12/208,667 →
Publication:
US 2009/0076018
Deuterium-Enriched Risperidone
Deuterium-Enriched Rivaroxaban
Application:
12/208,703 →
Publication:
US 2009/0076264
Deuterium-Enriched Ropinirole
Application:
12/206,307 →
Publication:
US 2009/0076124
Deuterium-Enriched Rosiglitazone
Application:
12/206,316 →
Publication:
US 2009/0076093
Deuterium-Enriched Saredutant
Application:
12/210,314 →
Publication:
US 2009/0076083
Deuterium-Enriched Senicapoc
Application:
12/208,716 →
Publication:
US 2009/0076157
Deuterium-Enriched Tafenoquine
Application:
12/206,330 →
Publication:
US 2009/0076072
Deuterium-Enriched Tapentadol
Application:
12/208,731 →
Publication:
US 2009/0076164
Deuterium-Enriched Telaprevir
Application:
12/233,655 →
Publication:
US 2009/0082366
Deuterium-Enriched Topiramate
Application:
12/208,743 →
Publication:
US 2009/0076128
Deuterium-Enriched Topotecan
Deuterium-Enriched Trabectedin
Application:
12/208,756 →
Publication:
US 2009/0076017
Deuterium-Enriched Tramiprosate
Application:
12/208,872 →
Publication:
US 2009/0076167
Deuterium-Enriched Valacyclovir
Application:
12/206,396 →
Publication:
US 2009/0076039
Deuterium-Enriched Valganciclovir
Application:
12/208,773 →
Publication:
US 2009/0076040
Deuterium-Enriched Zanamivir
Application:
12/206,405 →
Publication:
US 2009/0076133
Deuterium-Enriched Buprenorphine
Application:
12/233,657 →
Publication:
US 2009/0082383
Deuterium-Enriched Carvediolo
Application:
12/205,712 →
Publication:
US 2009/0076116
Deuterium-Enriched Desloratidine
Application:
12/233,665 →
Publication:
US 2009/0082385
Deuterium-Enriched Eplivanserin
Application:
12/210,321 →
Publication:
US 2009/0076159
Deuterium-Enriched Etoricoxib
Application:
12/208,888 →
Publication:
US 2009/0076087
Deuterium-Enriched Fexofenadine
Application:
12/210,326 →
Publication:
US 2009/0076080
Deuterium-Enriched Finasteride
Application:
12/208,901 →
Publication:
US 2009/0076058
Deuterium-Enriched Fosaprepitant
Application:
12/208,919 →
Publication:
US 2009/0076008
Deuterium-Enriched Imatinib
Application:
12/233,677 →
Publication:
US 2009/0082361
Deuterium-Enriched Lapaquistat
Application:
12/233,690 →
Publication:
US 2009/0088416
Deuterium-Enriched Laropiprant
Application:
12/208,936 →
Publication:
US 2009/0076117
Deuterium-Enriched Larotaxel
Application:
12/210,330 →
Publication:
US 2009/0076127
Deuterium-Enriched Levalbuterol
Application:
12/233,695 →
Publication:
US 2009/0082468
Deuterium-Enriched Levocedtirizine
Application:
12/233,702 →
Publication:
US 2009/0082364
Deuterium-Enriched Losartan
Application:
12/208,959 →
Publication:
US 2009/0076104
Deuterium-Enriched Lubiprostone
Application:
12/233,712 →
Publication:
US 2009/0082442
Deuterium-Enriched Lumiracoxib
Application:
12/233,719 →
Publication:
US 2009/0082452
Deuterium-Enriched Mk-0812
Application:
12/208,970 →
Publication:
US 2009/0076065
Deuterium-Enriched MK0974
Application:
12/208,981 →
Publication:
US 2009/0075977
Deuterium-Enriched Mometasone
Application:
12/233,725 →
Publication:
US 2009/0082318
Deuterium-Enriched Nvp-BEZ234
Application:
12/233,734 →
Publication:
US 2009/0082387
Deuterium-Enriched Oxalplatin
Application:
12/210,339 →
Publication:
US 2009/0076139
Deuterium-Enriched Oxcarbazepine
Application:
12/233,743 →
Publication:
US 2009/0082335
Deuterium-Enriched Pioglitazone
Deuterium-Enriched Posaconazole
Application:
12/234,229 →
Publication:
US 2009/0082363
Deuterium-Enriched Ramelteon
Application:
12/234,290 →
Publication:
US 2009/0082432
Deuterium-Enriched Ramipril
Application:
12/210,385 →
Publication:
US 2009/0076119
Deuterium-Enriched Satavaptan
Application:
12/210,391 →
Publication:
US 2009/0075997
Deuterium-Enriched Simvastatin
Application:
12/209,005 →
Publication:
US 2009/0076134
Deuterium-Enriched Sitagliptin
Application:
12/209,020 →
Publication:
US 2009/0076013
Deuterium-Enriched Sumatriptan
Application:
12/206,417 →
Publication:
US 2009/0076121
Deuterium-Enriched Tazobactam
Application:
12/209,031 →
Publication:
US 2009/0075966
Deuterium-Enriched Telbivudine
Application:
12/234,317 →
Publication:
US 2009/0082306
Deuterium-Enriched Telithromycin
Application:
12/210,405 →
Publication:
US 2009/0075917
Deuterium-Enriched Temsirolimus
Application:
12/209,043 →
Publication:
US 2009/0076060
Apparatus for and Method of Servicing Conveyor Belt Return Rollers During Belt Operation
Deuterium-Enriched Tigecycline
Application:
12/210,290 →
Publication:
US 2009/0076153
Deuterium-Enriched Tirapazamine
Application:
12/210,413 →
Publication:
US 2009/0076011
Deuterium-Enriched Vorinostat
Application:
12/210,298 →
Publication:
US 2009/0076154
Deuterium-Enriched Xaliproden
Application:
12/210,431 →
Publication:
US 2009/0076048
Deuterium-Enriched Zolpidem
Application:
12/210,438 →
Publication:
US 2009/0076066
Deuterium-Enriched Escitalopram
PCT:
PCT/US2008/066802 ↗
Deuterium-Enriched Montelukast
PCT:
PCT/US2008/067432 ↗
Deuterium-Enriched Olanzapine
PCT:
PCT/US2008/067256 ↗
Deuterium-Enriched Clopidogrel
PCT:
PCT/US2008/067257 ↗
Deuterium-Enriched Eszopiclone
PCT:
PCT/US2008/067258 ↗
Deuterium-Enriched Ezetimibe
PCT:
PCT/US2008/067259 ↗
Deuterium-Enriched Fluticasone Propionate
PCT:
PCT/US2008/067422 ↗
Deuterium-Enriched Oseltamivir
PCT:
PCT/US2008/067425 ↗
Deuterium-Enriched Salmeterol
PCT:
PCT/US2008/067429 ↗
Deuterium-Enriched Tenofovir
PCT:
PCT/US2008/067431 ↗
Deuterium-Enriched Tamsulosin
PCT:
PCT/US2008/066804 ↗
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.